Non-esterified fatty acids: Another piece in the puzzle of PAD risk stratification?

Atherosclerosis. 2023 Apr:370:1-2. doi: 10.1016/j.atherosclerosis.2023.03.001. Epub 2023 Mar 5.

Authors

Bernhard Zierfuss¹, Herbert Stangl², Gerit-Holger Schernthaner³

Affiliations

¹ Division of Angiology, Department of Medicine, Medical University of Vienna, Austria.
² Center of Pathobiochemistry and Genetics, Institute for Medical Chemistry, Medical University of Vienna, Austria.
³ Division of Angiology, Department of Medicine, Medical University of Vienna, Austria. Electronic address: gerit.schernthaner@meduniwien.ac.at.

PMID: 36914540
DOI: 10.1016/j.atherosclerosis.2023.03.001

No abstract available

Keywords: Low-density lipoprotein cholesterol; Non-esterified fatty acids; Peripheral artery disease.

Publication types

Editorial
Comment

MeSH terms

Fatty Acids
Fatty Acids, Nonesterified*
Lipoproteins, HDL*
Risk Assessment

Substances

Fatty Acids, Nonesterified
Lipoproteins, HDL
Fatty Acids